NLRP3 as a potentially novel biomarker for the management of osteoarthritis

Osteoarthritis (OA) was previously thought of as ‘wear and tear’ as humans age, however there is increasing evidence to support an inflammatory theory. The nucleotide-binding and oligomerization domain-like receptor containing protein 3 (NLRP3) inflammasome has been implicated in the pathogenesis of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Osteoarthritis and cartilage 2018-05, Vol.26 (5), p.612-619
Hauptverfasser:	McAllister, M.J., Chemaly, M., Eakin, A.J., Gibson, D.S., McGilligan, V.E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarker Inflammasome Inflammation NLRP3 Osteoarthritis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	619
container_issue	5
container_start_page	612
container_title	Osteoarthritis and cartilage
container_volume	26
creator	McAllister, M.J. Chemaly, M. Eakin, A.J. Gibson, D.S. McGilligan, V.E.
description	Osteoarthritis (OA) was previously thought of as ‘wear and tear’ as humans age, however there is increasing evidence to support an inflammatory theory. The nucleotide-binding and oligomerization domain-like receptor containing protein 3 (NLRP3) inflammasome has been implicated in the pathogenesis of a number of arthritic disorders, producing proinflammatory cytokines and degradative enzymes such as Interleukin-1 beta (IL-1β), Tumour necrosis factor alpha (TNF-α) and Matrix metalloproteinase-3 (MMP-3) which drive cartilage degeneration and synovial inflammation. This review aims to summarise the evidence of NLRP3 involvement in OA. Currently, treatment options focus on management of the disease and to date there is no cure. The development of novel biomarkers for OA could improve diagnosis, treatment and management. Importantly, this review provides detail on the involvement of the NLRP3 inflammasome in OA pathology and how its members could act as potential biomarkers to assist clinical decisions.
doi_str_mv	10.1016/j.joca.2018.02.901
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2010376270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1063458418310604</els_id><sourcerecordid>2010376270</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-30ba2127954b054056a9135ba6d63d79a47643e9d1cf0a7694b650ba2a6c5463</originalsourceid><addsrcrecordid>eNp9kM1u1DAUhS1ERX_gBVggL9kkXP8mltigqkClUYtQ95bj3FAPSTzYnkp9G56FJ8OjKSy7unfxnSOdj5C3DFoGTH_YttvoXcuB9S3w1gB7Qc6Y4rwxWomX9QctGql6eUrOc94CgGAMXpFTbqQxvO_PyOZm8_2boC5TR3ex4FqCm-dHusYHnOkQ4uLST0x0iomWe6SLW90PXCpH4_Tnd8wFo0vlPoUS8mtyMrk545une0HuPl_dXX5tNrdfri8_bRovuS6NgMFxxjuj5ABKgtLOMKEGp0ctxs442Wkp0IzMT-A6beSg1SHjtFdSiwvy_li7S_HXHnOxS8ge59mtGPfZViEgOs07qCg_oj7FnBNOdpdCnfRoGdiDRLu1B4mHTG-B2yqxht499e-HBcf_kX_WKvDxCGAd-RAw2ewDrh7HkNAXO8bwXP9fYteCnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2010376270</pqid></control><display><type>article</type><title>NLRP3 as a potentially novel biomarker for the management of osteoarthritis</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>McAllister, M.J. ; Chemaly, M. ; Eakin, A.J. ; Gibson, D.S. ; McGilligan, V.E.</creator><creatorcontrib>McAllister, M.J. ; Chemaly, M. ; Eakin, A.J. ; Gibson, D.S. ; McGilligan, V.E.</creatorcontrib><description>Osteoarthritis (OA) was previously thought of as ‘wear and tear’ as humans age, however there is increasing evidence to support an inflammatory theory. The nucleotide-binding and oligomerization domain-like receptor containing protein 3 (NLRP3) inflammasome has been implicated in the pathogenesis of a number of arthritic disorders, producing proinflammatory cytokines and degradative enzymes such as Interleukin-1 beta (IL-1β), Tumour necrosis factor alpha (TNF-α) and Matrix metalloproteinase-3 (MMP-3) which drive cartilage degeneration and synovial inflammation. This review aims to summarise the evidence of NLRP3 involvement in OA. Currently, treatment options focus on management of the disease and to date there is no cure. The development of novel biomarkers for OA could improve diagnosis, treatment and management. Importantly, this review provides detail on the involvement of the NLRP3 inflammasome in OA pathology and how its members could act as potential biomarkers to assist clinical decisions.</description><identifier>ISSN: 1063-4584</identifier><identifier>EISSN: 1522-9653</identifier><identifier>DOI: 10.1016/j.joca.2018.02.901</identifier><identifier>PMID: 29499288</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biomarker ; Inflammasome ; Inflammation ; NLRP3 ; Osteoarthritis</subject><ispartof>Osteoarthritis and cartilage, 2018-05, Vol.26 (5), p.612-619</ispartof><rights>2018 Osteoarthritis Research Society International</rights><rights>Copyright © 2018 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-30ba2127954b054056a9135ba6d63d79a47643e9d1cf0a7694b650ba2a6c5463</citedby><cites>FETCH-LOGICAL-c426t-30ba2127954b054056a9135ba6d63d79a47643e9d1cf0a7694b650ba2a6c5463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.joca.2018.02.901$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29499288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McAllister, M.J.</creatorcontrib><creatorcontrib>Chemaly, M.</creatorcontrib><creatorcontrib>Eakin, A.J.</creatorcontrib><creatorcontrib>Gibson, D.S.</creatorcontrib><creatorcontrib>McGilligan, V.E.</creatorcontrib><title>NLRP3 as a potentially novel biomarker for the management of osteoarthritis</title><title>Osteoarthritis and cartilage</title><addtitle>Osteoarthritis Cartilage</addtitle><description>Osteoarthritis (OA) was previously thought of as ‘wear and tear’ as humans age, however there is increasing evidence to support an inflammatory theory. The nucleotide-binding and oligomerization domain-like receptor containing protein 3 (NLRP3) inflammasome has been implicated in the pathogenesis of a number of arthritic disorders, producing proinflammatory cytokines and degradative enzymes such as Interleukin-1 beta (IL-1β), Tumour necrosis factor alpha (TNF-α) and Matrix metalloproteinase-3 (MMP-3) which drive cartilage degeneration and synovial inflammation. This review aims to summarise the evidence of NLRP3 involvement in OA. Currently, treatment options focus on management of the disease and to date there is no cure. The development of novel biomarkers for OA could improve diagnosis, treatment and management. Importantly, this review provides detail on the involvement of the NLRP3 inflammasome in OA pathology and how its members could act as potential biomarkers to assist clinical decisions.</description><subject>Biomarker</subject><subject>Inflammasome</subject><subject>Inflammation</subject><subject>NLRP3</subject><subject>Osteoarthritis</subject><issn>1063-4584</issn><issn>1522-9653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kM1u1DAUhS1ERX_gBVggL9kkXP8mltigqkClUYtQ95bj3FAPSTzYnkp9G56FJ8OjKSy7unfxnSOdj5C3DFoGTH_YttvoXcuB9S3w1gB7Qc6Y4rwxWomX9QctGql6eUrOc94CgGAMXpFTbqQxvO_PyOZm8_2boC5TR3ex4FqCm-dHusYHnOkQ4uLST0x0iomWe6SLW90PXCpH4_Tnd8wFo0vlPoUS8mtyMrk545une0HuPl_dXX5tNrdfri8_bRovuS6NgMFxxjuj5ABKgtLOMKEGp0ctxs442Wkp0IzMT-A6beSg1SHjtFdSiwvy_li7S_HXHnOxS8ge59mtGPfZViEgOs07qCg_oj7FnBNOdpdCnfRoGdiDRLu1B4mHTG-B2yqxht499e-HBcf_kX_WKvDxCGAd-RAw2ewDrh7HkNAXO8bwXP9fYteCnw</recordid><startdate>20180501</startdate><enddate>20180501</enddate><creator>McAllister, M.J.</creator><creator>Chemaly, M.</creator><creator>Eakin, A.J.</creator><creator>Gibson, D.S.</creator><creator>McGilligan, V.E.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180501</creationdate><title>NLRP3 as a potentially novel biomarker for the management of osteoarthritis</title><author>McAllister, M.J. ; Chemaly, M. ; Eakin, A.J. ; Gibson, D.S. ; McGilligan, V.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-30ba2127954b054056a9135ba6d63d79a47643e9d1cf0a7694b650ba2a6c5463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Biomarker</topic><topic>Inflammasome</topic><topic>Inflammation</topic><topic>NLRP3</topic><topic>Osteoarthritis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McAllister, M.J.</creatorcontrib><creatorcontrib>Chemaly, M.</creatorcontrib><creatorcontrib>Eakin, A.J.</creatorcontrib><creatorcontrib>Gibson, D.S.</creatorcontrib><creatorcontrib>McGilligan, V.E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Osteoarthritis and cartilage</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McAllister, M.J.</au><au>Chemaly, M.</au><au>Eakin, A.J.</au><au>Gibson, D.S.</au><au>McGilligan, V.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NLRP3 as a potentially novel biomarker for the management of osteoarthritis</atitle><jtitle>Osteoarthritis and cartilage</jtitle><addtitle>Osteoarthritis Cartilage</addtitle><date>2018-05-01</date><risdate>2018</risdate><volume>26</volume><issue>5</issue><spage>612</spage><epage>619</epage><pages>612-619</pages><issn>1063-4584</issn><eissn>1522-9653</eissn><abstract>Osteoarthritis (OA) was previously thought of as ‘wear and tear’ as humans age, however there is increasing evidence to support an inflammatory theory. The nucleotide-binding and oligomerization domain-like receptor containing protein 3 (NLRP3) inflammasome has been implicated in the pathogenesis of a number of arthritic disorders, producing proinflammatory cytokines and degradative enzymes such as Interleukin-1 beta (IL-1β), Tumour necrosis factor alpha (TNF-α) and Matrix metalloproteinase-3 (MMP-3) which drive cartilage degeneration and synovial inflammation. This review aims to summarise the evidence of NLRP3 involvement in OA. Currently, treatment options focus on management of the disease and to date there is no cure. The development of novel biomarkers for OA could improve diagnosis, treatment and management. Importantly, this review provides detail on the involvement of the NLRP3 inflammasome in OA pathology and how its members could act as potential biomarkers to assist clinical decisions.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29499288</pmid><doi>10.1016/j.joca.2018.02.901</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1063-4584
ispartof	Osteoarthritis and cartilage, 2018-05, Vol.26 (5), p.612-619
issn	1063-4584 1522-9653
language	eng
recordid	cdi_proquest_miscellaneous_2010376270
source	Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ScienceDirect Journals (5 years ago - present)
subjects	Biomarker Inflammasome Inflammation NLRP3 Osteoarthritis
title	NLRP3 as a potentially novel biomarker for the management of osteoarthritis
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T06%3A51%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NLRP3%20as%20a%20potentially%20novel%20biomarker%20for%20the%20management%20of%C2%A0osteoarthritis&rft.jtitle=Osteoarthritis%20and%20cartilage&rft.au=McAllister,%20M.J.&rft.date=2018-05-01&rft.volume=26&rft.issue=5&rft.spage=612&rft.epage=619&rft.pages=612-619&rft.issn=1063-4584&rft.eissn=1522-9653&rft_id=info:doi/10.1016/j.joca.2018.02.901&rft_dat=%3Cproquest_cross%3E2010376270%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2010376270&rft_id=info:pmid/29499288&rft_els_id=S1063458418310604&rfr_iscdi=true